biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s): BIOAF

Healthcare Biotechnology

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.

TSXV:BTI.H - Post by User

biOasis Technologies Ord Shs

<< Previous

Bullboard Posts

Next >>

Post by greaterfoolFredon Jan 18, 2021 5:52pm

260 Views

Post# 32322768

Biotech showcase

First of all, this was a good day. Let's hope it's one of a long string of good days.

Does anyone know what happened with our attendance at Biotech showcase? Here is the news release;

https://stockhouse.com/news/press-releases/2021/01/04/bioasis-to-present-at-upcoming-industry-conferences

The title states that Bioasis will present, then the text states that Dr. Rathjen will attend. Bioasis is not listed among the presenters. I thought our recent climb action might have been due to a good reception at Biotech showcase, but Bioasis is not listed as a presenter. What happened?

<< Previous

Bullboard Posts

Next >>

BCG-Unresponsive Non-Muscle Invasive Bladder Cancer Carcinoma-In-Situ: A Patient's Guide